MiRNome traits analysis on endothelial lineage cells discloses biomarker potential circulating microRNAs which affect progenitor activities

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Chang, Ting Yu ^a   Huang, Tse Shun ^a,b   Wang, Hsei Wei ^a,c   Chang, Shing Jyh ^d   Lo, Hung Hao ^a   Chiu, Ya Lin ^a   Wang, Yen Li ^a   Hsiao, Chung Der ^e   Tsai, Chin Han ^d   Chan, Chia Hao ^d   You, Ren In ^f   Wu, Chun Hsien ^g   Tsai, Tsung Neng ^g   Cheng, Shu Meng ^g   Cheng, Cheng Chung ^g  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

^g TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Circulating microRNA; Coronary artery disease; Endothelial progenitor cell; MicroRNA 221 222; smRNA seq

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 221; MICRORNA 222; TRANSFORMING GROWTH FACTOR BETA; ETS1 PROTEIN, HUMAN; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3R1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL HYPOXIA; CELL LINEAGE; CELL MATURATION; CELL MOTILITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EMBRYO; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENERGY RESOURCE; GENE CLUSTER; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRAIT; GENOME ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; RNA SEQUENCE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; ZEBRA FISH; ANIMAL; BLOOD; CELL CULTURE; CYTOLOGY; FEMALE; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; METABOLISM; PREGNANCY; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BIOMARKERS; CELLS, CULTURED; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PREGNANCY; PROTO-ONCOGENE PROTEIN C-ETS-1; SEQUENCE ANALYSIS, RNA; ZEBRAFISH;

EID: 84907915213     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-802     Document Type: Article

References (51)

1. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353(10):999-1007. 10.1056/NEJMoa043814, 16148285.
2. Grisar JC, Haddad F, Gomari FA, Wu JC. Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomark Med 2011, 5(6):731-744. 10.2217/bmm.11.92, 3285378, 22103609.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967. 10.1126/science.275.5302.964, 9020076.
4. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002, 109(3):337-346. 10.1172/JCI0214327, 150857, 11827993.
5. Real C, Caiado F, Dias S. Endothelial progenitors in vascular repair and angiogenesis: how many are needed and what to do?. Cardiovasc Hematol Disord Drug Targets 2008, 8(3):185-193. 10.2174/187152908785849071, 18781931.
6. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 2003, 13(5):201-206. 10.1016/S1050-1738(03)00077-X, 12837583.
7. Briasoulis A, Tousoulis D, Antoniades C, Stefanadis C, Papageorgiou N. The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovasc Ther 2010, 29(2):125-139.
8. Jialal I, Devaraj S, Singh U, Huet BA. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis 2010, 211(1):297-302. 10.1016/j.atherosclerosis.2010.01.036, 2902610, 20171637.
9. Critser PJ, Voytik-Harbin SL, Yoder MC. Isolating and defining cells to engineer human blood vessels. Cell Prolif 2011, 44(Suppl 1):15-21. 3387928, 21481038.
10. Yoder MC. Endothelial progenitor cell: a blood cell by many other names may serve similar functions. J Mol Med (Berl) 2013, 91(3):285-295. 10.1007/s00109-013-1002-8, 3704045, 23371317.
11. Cheng CC, Chang SJ, Chueh YN, Huang TS, Huang PH, Cheng SM, Tsai TN, Chen JW, Wang HW. Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses. BMC Genomics 2013, 14(1):182. 10.1186/1471-2164-14-182, 3652793, 23496821.
12. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005, 122(1):6-7. 10.1016/j.cell.2005.06.036, 16009126.
13. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433(7027):769-773. 10.1038/nature03315, 15685193.
14. Wang QZ, Xu W, Habib N, Xu R. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets 2009, 9(4):572-594. 10.2174/156800909788486731, 19519323.
15. Brase JC, Wuttig D, Kuner R, Sultmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 2010, 9:306. 10.1186/1476-4598-9-306, 3002336, 21110877.
16. Iguchi H, Kosaka N, Ochiya T. Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkers. Curr Drug Discov Technol 2010, 7(2):95-105. 10.1016/j.ddtec.2010.11.008, 20836759.
17. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S, Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108(9):3068-3071. 10.1182/blood-2006-01-012369, 16849646.
18. Kuehbacher A, Urbich C, Dimmeler S. Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 2008, 29(1):12-15. 10.1016/j.tips.2007.10.014, 18068232.
19. Minami Y, Satoh M, Maesawa C, Takahashi Y, Tabuchi T, Itoh T, Nakamura M. Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest 2009, 39(5):359-367. 10.1111/j.1365-2362.2009.02110.x, 19371267.
20. Zhang Q, Kandic I, Kutryk MJ. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem Biophys Res Commun 2011, 405(1):42-46. 10.1016/j.bbrc.2010.12.119, 21195052.
21. Cheng CC, Lo HH, Huang TS, Cheng YC, Chang ST, Chang SJ, Wang HW. Genetic module and miRNome trait analyses reflect the distinct biological features of endothelial progenitor cells from different anatomic locations. BMC Genomics 2012, 13(1):447. 10.1186/1471-2164-13-447, 3443421, 22943456.
22. Wang HW, Huang TS, Lo HH, Huang PH, Lin CC, Chang SJ, Liao KH, Tsai CH, Chan CH, Tsai CF, Cheng YC, Chiu YL, Tsai TN, Cheng CC, Cheng SM. Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2014, 34(4):857-869. 10.1161/ATVBAHA.113.303001, 24558106.
23. Plummer PN, Freeman R, Taft RJ, Vider J, Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, Ferro V, McMillan NA, Swarbrick A, Mittal V, Mellick AS. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res 2013, 73(1):341-352. 10.1158/0008-5472.CAN-12-0271, 22836757.
24. Goff LA, Davila J, Swerdel MR, Moore JC, Cohen RI, Wu H, Sun YE, Hart RP. Ago2 immunoprecipitation identifies predicted microRNAs in human embryonic stem cells and neural precursors. PLoS One 2009, 4(9):e7192. 10.1371/journal.pone.0007192, 2745660, 19784364.
25. Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, Kroh EM, Bendoraite A, Mitchell PS, Nelson AM, Ruzzo WL, Ware C, Radich JP, Gentleman R, Ruohola-Baker H, Tewari M. MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 2008, 26(10):2496-2505. 10.1634/stemcells.2008-0356, 2847579, 18583537.
26. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, Eaves CJ, Marra MA. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 2008, 18(4):610-621. 10.1101/gr.7179508, 2279248, 18285502.
27. Skreka K, Schafferer S, Nat IR, Zywicki M, Salti A, Apostolova G, Griehl M, Rederstorff M, Dechant G, Huttenhofer A. Identification of differentially expressed non-coding RNAs in embryonic stem cell neural differentiation. Nucleic Acids Res 2012, 40(13):6001-6015. 10.1093/nar/gks311, 3401476, 22492625.
28. Bissels U, Wild S, Tomiuk S, Hafner M, Scheel H, Mihailovic A, Choi YH, Tuschl T, Bosio A. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Stem Cells 2011, 29(5):847-857. 10.1002/stem.627, 3116150, 21394831.
29. Yoo JK, Kim J, Choi SJ, Noh HM, Kwon YD, Yoo H, Yi HS, Chung HM, Kim JK. Discovery and characterization of novel microRNAs during endothelial differentiation of human embryonic stem cells. Stem Cells Dev 2012, 21(11):2049-2057. 10.1089/scd.2011.0500, 3396149, 22142236.
30. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, Liu PL, Chen YL, Chen JW. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007, 56(6):1559-1568. 10.2337/db06-1103, 17389326.
31. Wu YH, Hu TF, Chen YC, Tsai YN, Tsai YH, Cheng CC, Wang HW. The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood 2011, 118(10):2896-2905. 10.1182/blood-2011-01-330589, 21715310.
32. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33(20):e179. 10.1093/nar/gni178, 1292995, 16314309.
33. Cheng WC, Chung IF, Huang TS, Chang ST, Sun HJ, Tsai CF, Liang ML, Wong TT, Wang HW. YM500: a small RNA sequencing (smRNA-seq) database for microRNA research. Nucleic Acids Res 2013, 41(D1):D285-D294. 10.1093/nar/gks1238, 3531161, 23203880.
34. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008, 5(7):621-628. 10.1038/nmeth.1226, 18516045.
35. Hsieh JY, Huang TS, Cheng SM, Lin WS, Tsai TN, Lee OK, Wang HW. miR-146a-5p circuitry uncouples cell proliferation and migration, but not differentiation, in human mesenchymal stem cells. Nucleic Acids Res 2013, 41(21):9753-9763. 10.1093/nar/gkt666, 3834804, 23963696.
36. Goretti E, Rolland-Turner M, Leonard F, Zhang L, Wagner DR, Devaux Y. MicroRNA-16 affects key functions of human endothelial progenitor cells. J Leukoc Biol 2013, 93(5):645-655. 10.1189/jlb.1012511, 23325924.
37. Cui Y, Han Z, Hu Y, Song G, Hao C, Xia H, Ma X. MicroRNA-181b and microRNA-9 mediate arsenic-induced angiogenesis via NRP1. J Cell Physiol 2012, 227(2):772-783. 10.1002/jcp.22789, 21503876.
38. Sun X, He S, Wara AK, Icli B, Shvartz E, Tesmenitsky Y, Belkin N, Li D, Blackwell TS, Sukhova GK, Croce K, Feinberg MW. Systemic delivery of microRNA-181b inhibits nuclear factor-kappaB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res 2014, 114(1):32-40. 10.1161/CIRCRESAHA.113.302089, 4051320, 24084690.
39. Nicoli S, Knyphausen CP, Zhu LJ, Lakshmanan A, Lawson ND. miR-221 is required for endothelial tip cell behaviors during vascular development. Dev Cell 2012, 22(2):418-429. 10.1016/j.devcel.2012.01.008, 3285411, 22340502.
40. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107(5):677-684. 10.1161/CIRCRESAHA.109.215566, 20595655.
41. Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N, Ziemann M, Helbing T, El-Osta A, Jowett JB, Peter K. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012, 93(4):633-644. 10.1093/cvr/cvs007, 3291092, 22258631.
42. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89(1):E1-E7. 10.1161/hh1301.093953, 11440984.
43. Briguori C, Testa U, Riccioni R, Colombo A, Petrucci E, Condorelli G, Mariani G, D'Andrea D, De Micco F, Rivera NV, Puca AA, Peschle C. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. Faseb J 2010, 24(6):1981-1988. 10.1096/fj.09-138198, 20056714.
44. Fuchs S, Dohle E, Kolbe M, Kirkpatrick CJ. Outgrowth endothelial cells: sources, characteristics and potential applications in tissue engineering and regenerative medicine. Adv Biochem Eng Biotechnol 2010, 123:201-217.
45. Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, Kao SY, Wu KJ, Hung MC, Yang MH. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 2012, 14(4):366-374. 10.1038/ncb2455, 22407364.
46. Maeng YS, Choi HJ, Kwon JY, Park YW, Choi KS, Min JK, Kim YH, Suh PG, Kang KS, Won MH, Kim YM, Kwon YG. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 2009, 113(1):233-243. 10.1182/blood-2008-06-162891, 18832656.
47. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009, 10(1):57-63. 10.1038/nrg2484, 2949280, 19015660.
48. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, Vanderheyden M, Kim HS, Kang HJ, Strauer BE, Vetrovec GW. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007, 50(18):1761-1767. 10.1016/j.jacc.2007.07.041, 17964040.
49. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, Poh KK, Weinstein R, Kearney M, Chaudhry M, Burg A, Eaton L, Heyd L, Thorne T, Shturman L, Hoffmeister P, Story K, Zak V, Dowling D, Traverse JH, Olson RE, Flanagan J, Sodano D, Murayama T, Kawamoto A, Kusano KF, Wollins J, Welt F, Shah P, Soukas P. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115(25):3165-3172. 10.1161/CIRCULATIONAHA.106.687376, 17562958.
50. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A 2005, 102(50):18081-18086. 10.1073/pnas.0506216102, 1312381, 16330772.
51. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107(9):1322-1328. 10.1161/01.CIR.0000055313.77510.22, 12628955.